Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5G23D | — |
Kinrix was the patient's 3rd dose of DTaP and IPV; nurse assistant administered Kinrix to an underage child; administered Kinrix to an underage child instead of separate Dtap and Polio vaccines; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate schedule of vaccine administered in a 6-month-old male patient who received DTPa-IPV (Kinrix) (batch number 5G23D, expiry date 21-AUG-2026) for prophylaxis. On 05-MAR-2025, the patient received Kinrix. On 05-MAR-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate schedule of vaccine administered (Verbatim: Kinrix was the patient's 3rd dose of DTaP and IPV), inappropriate age at vaccine administration (Verbatim: nurse assistant administered Kinrix to an underage child) and wrong vaccine administered (Verbatim: administered Kinrix to an underage child instead of separate Dtap and Polio vaccines). The outcome of the inappropriate schedule of vaccine administered, inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-MAR-2025 A nurse assistant administered Kinrix which was the patient's 3rd dose of DTaP and IPV to an underage child instead of separate Dtap and Polio vaccines which led to inappropriate age at vaccine administration, inappropriate schedule of vaccine administered and wrong vaccine administered. The Vaccine Administration Facility is the same as Primary Reporter.